blue bird - BLBD
BLBD
Close Chg Chg %
55.54 3.67 6.61%
Closed Market
59.21
+3.67 (6.61%)
Volume: 717.12K
Last Updated:
Feb 6, 2026, 4:00 PM EDT
Company Overview: blue bird - BLBD
BLBD Key Data
| Open $55.78 | Day Range 55.78 - 59.35 |
| 52 Week Range 30.15 - 61.95 | Market Cap $1.57B |
| Shares Outstanding 31.59M | Public Float 31.20M |
| Beta 1.44 | Rev. Per Employee N/A |
| P/E Ratio 14.01 | EPS $4.09 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 511.87K |
BLBD Performance
| 1 Week | 17.69% | ||
| 1 Month | 22.26% | ||
| 3 Months | 17.57% | ||
| 1 Year | 55.77% | ||
| 5 Years | 169.63% |
BLBD Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
8
Full Ratings ➔
About blue bird - BLBD
Blue Bird Corp. engages in the design and manufacture of school buses. It operates through the Bus and Parts segments. The Bus segment includes the manufacturing and assembly of school buses to be sold to a variety of customers across the United States, Canada, and in international markets. The Parts segment focuses on the purchases of parts from third parties to be sold to dealers within the company’s network and certain large fleet customers. The company was founded by Albert Laurence Luce in 1927 and is headquartered in Macon, GA.
BLBD At a Glance
Blue Bird Corp.
3920 Arkwright Road
Macon, Georgia 31210
| Phone | 1-478-822-2801 | Revenue | 1.48B | |
| Industry | Motor Vehicles | Net Income | 127.72M | |
| Sector | Consumer Durables | 2025 Sales Growth | 9.869% | |
| Fiscal Year-end | 09 / 2026 | Employees | 2,012 | |
| View SEC Filings |
BLBD Valuation
| P/E Current | 14.008 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 14.92 |
| Price to Sales Ratio | 1.287 |
| Price to Book Ratio | 7.234 |
| Price to Cash Flow Ratio | 10.81 |
| Enterprise Value to EBITDA | 9.716 |
| Enterprise Value to Sales | 1.198 |
| Total Debt to Enterprise Value | 0.054 |
BLBD Efficiency
| Revenue/Employee | 735,635.686 |
| Income Per Employee | 63,479.125 |
| Receivables Turnover | 71.675 |
| Total Asset Turnover | 2.469 |
BLBD Liquidity
| Current Ratio | 1.738 |
| Quick Ratio | 1.149 |
| Cash Ratio | 0.968 |
BLBD Profitability
| Gross Margin | 20.506 |
| Operating Margin | 11.294 |
| Pretax Margin | 11.456 |
| Net Margin | 8.629 |
| Return on Assets | 21.305 |
| Return on Equity | 61.555 |
| Return on Total Capital | 36.282 |
| Return on Invested Capital | 42.767 |
BLBD Capital Structure
| Total Debt to Total Equity | 37.823 |
| Total Debt to Total Capital | 27.443 |
| Total Debt to Total Assets | 14.825 |
| Long-Term Debt to Equity | 34.974 |
| Long-Term Debt to Total Capital | 25.376 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Blue Bird - BLBD
Collapse All in section
| All values USD millions. | 2022 | 2023 | 2024 | 2025 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 800.64M | 1.13B | 1.35B | 1.48B | |
Sales Growth
| +17.05% | +41.49% | +18.92% | +9.87% | |
Cost of Goods Sold (COGS) incl D&A
| 765.19M | 995.74M | 1.09B | 1.18B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 15.15M | 17.10M | 14.10M | 15.30M | |
Depreciation
| 13.15M | 15.10M | 12.20M | 13.40M | |
Amortization of Intangibles
| 2.00M | 2.00M | 1.90M | 1.90M | |
COGS Growth
| +24.90% | +30.13% | +9.73% | +7.69% | |
Gross Income
| 35.45M | 137.05M | 254.56M | 303.51M | |
Gross Income Growth
| -50.31% | +286.64% | +85.74% | +19.23% | |
Gross Profit Margin
| +4.43% | +12.10% | +18.90% | +20.51% |
| 2022 | 2023 | 2024 | 2025 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 75.90M | 85.39M | 115.22M | 136.35M | |
Research & Development
| 6.10M | 6.60M | 9.40M | 15.20M | |
Other SG&A
| 69.80M | 78.79M | 105.83M | 121.15M | |
SGA Growth
| +18.30% | +12.51% | +34.93% | +18.33% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| - | 917.00K | 537.00K | 1.56M | |
EBIT after Unusual Expense
| (41.37M) | 51.12M | 137.77M | 167.17M | |
Non Operating Income/Expense
| 3.00M | (7.30M) | (258.00K) | 9.60M | |
Non-Operating Interest Income
| 9.00K | 1.00M | 4.14M | 6.19M | |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 14.68M | 18.01M | 10.58M | 7.20M | |
Interest Expense Growth
| +51.57% | +22.74% | -41.27% | -31.92% | |
Gross Interest Expense
| 15.38M | 18.71M | 10.88M | 7.70M | |
Interest Capitalized
| 700.00K | 700.00K | 300.00K | 500.00K | |
Pretax Income
| (53.05M) | 25.80M | 126.94M | 169.56M | |
Pretax Income Growth
| -2,582.05% | +148.64% | +391.90% | +33.58% | |
Pretax Margin
| -6.63% | +2.28% | +9.42% | +11.46% | |
Income Tax
| (11.45M) | 8.95M | 33.23M | 43.93M | |
Income Tax - Current - Domestic
| (380.00K) | 888.00K | 34.63M | 41.26M | |
Income Tax - Current - Foreign
| - | - | 267.00K | (267.00K) | - |
Income Tax - Deferred - Domestic
| (11.07M) | 8.06M | (1.67M) | 2.94M | |
Income Tax - Deferred - Foreign
| - | - | - | - | - |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| (45.76M) | 23.81M | 105.55M | 127.72M | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| (45.76M) | 23.81M | 105.55M | 127.72M | |
Net Income Growth
| -15,733.56% | +152.04% | +343.25% | +21.01% | |
Net Margin Growth
| -5.72% | +2.10% | +7.83% | +8.63% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| (45.76M) | 23.81M | 105.55M | 127.72M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| (45.76M) | 23.81M | 105.55M | 127.72M | |
EPS (Basic)
| -1.4751 | 0.7425 | 3.2707 | 4.0086 | |
EPS (Basic) Growth
| -13,816.04% | +150.34% | +340.50% | +22.56% | |
Basic Shares Outstanding
| 31.02M | 32.07M | 32.27M | 31.86M | |
EPS (Diluted)
| -1.4751 | 0.7382 | 3.1649 | 3.884 | |
EPS (Diluted) Growth
| -13,816.04% | +150.04% | +328.73% | +22.72% | |
Diluted Shares Outstanding
| 31.02M | 32.26M | 33.35M | 32.88M | |
EBITDA
| (25.30M) | 68.76M | 153.43M | 182.47M | |
EBITDA Growth
| -218.09% | +371.72% | +123.15% | +18.92% | |
EBITDA Margin
| -3.16% | +6.07% | +11.39% | +12.33% |
Snapshot
| Average Recommendation | BUY | Average Target Price | 63.75 | |
| Number of Ratings | 8 | Current Quarters Estimate | 0.875 | |
| FY Report Date | 03 / 2026 | Current Year's Estimate | 4.476 | |
| Last Quarter’s Earnings | 1.00 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 4.38 | Next Fiscal Year Estimate | 4.902 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 8 | 8 | 8 | 7 |
| Mean Estimate | 0.87 | 1.20 | 4.48 | 4.90 |
| High Estimates | 0.99 | 1.35 | 4.89 | 5.39 |
| Low Estimate | 0.70 | 1.05 | 4.07 | 4.38 |
| Coefficient of Variance | 9.94 | 9.81 | 6.74 | 6.94 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 6 | 6 | 6 |
| OVERWEIGHT | 1 | 1 | 1 |
| HOLD | 1 | 1 | 1 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Buy | Buy | Buy |
SEC Filings for Blue Bird - BLBD
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Blue Bird - BLBD
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Dec 18, 2025 | Razvan Radulescu Chief Financial Officer | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Dec 18, 2025 | Razvan Radulescu Chief Financial Officer | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Dec 18, 2025 | Razvan Radulescu Chief Financial Officer | 46,180 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $51.58 per share | 2,381,964.40 |
| Dec 18, 2025 | Razvan Radulescu Chief Financial Officer | 53,186 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $12.35 per share | 656,847.10 |
| Dec 18, 2025 | Razvan Radulescu Chief Financial Officer | 49,683 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $12.35 per share | 613,585.05 |
| Dec 17, 2025 | Philip Horlock Director | 233,726 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $50.5 per share | 11,803,163.00 |
| Dec 17, 2025 | Ted Scartz SVP General Counsel | 59,910 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $50.36 per share | 3,017,067.60 |
| Dec 17, 2025 | Jeff Sanfrey Chief Operating Officer | 39,011 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $50.36 per share | 1,964,593.96 |
| Dec 17, 2025 | Philip Horlock Director | 225,385 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $50.35 per share | 11,348,134.75 |
| Dec 5, 2025 | John F. Wyskiel President & CEO; Director | 136,419 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Dec 5, 2025 | Jeff Sanfrey Chief Operating Officer | 34,159 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Dec 5, 2025 | John F. Wyskiel President & CEO; Director | 88,088 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $50.7 per share | 4,466,061.60 |
| Dec 5, 2025 | Jeff Sanfrey Chief Operating Officer | 40,313 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Dec 5, 2025 | John F. Wyskiel President & CEO; Director | 107,420 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Dec 5, 2025 | Ted Scartz SVP General Counsel | 53,336 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Dec 5, 2025 | Ted Scartz SVP General Counsel | 61,417 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Sep 16, 2025 | Philip Horlock Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Aug 20, 2025 | Philip Horlock Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Aug 20, 2025 | Philip Horlock Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Aug 20, 2025 | Philip Horlock Director | 240,766 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $58.16 per share | 14,002,950.56 |